Re: EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin
2016 ◽
Vol 195
(5)
◽
pp. 1382-1382
◽
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):